PURPOSE: Major depression is associated with high levels of absence and reduced productivity. Therefore the costs to society are high. The aim of this study was to evaluate the cost-utility of collaborative care for major depressive disorder (MDD) compared to care as usual in an occupational healthcare setting. A societal perspective was taken. METHODS: In this randomised controlled trial, 126 sick-listed workers with MDD were included (65 collaborative care, 61 care as usual). Baseline measurements and follow up measures (3, 6, 9 and 12 months) were assessed by questionnaire. We applied the Trimbos/iMTA questionnaire for costs associated with psychiatric illness, the SF-HQL and the EQ-5D respectively measuring the health care utilization, production losses and general health related quality of life. RESULTS: The average annual healthcare costs in the collaborative care group were €3,874 (95 % CI €2,778-€ 5,718) compared to €4,583 (95 % CI €3,108-€6,794) in the care as usual group. The average quality of life years (QALY's) gained were lower in the collaborative care group, 0.05 QALY. The majority of the ICERS (69 %) indicate that collaborative care is less costly but also less effective than care as usual. Including the productivity costs did not change this result. CONCLUSIONS: The cost-utility analysis showed that collaborative care generated reduced costs and a reduction in effects compared to care as usual and was therefore not a cost-effective intervention.
RCT Entities:
PURPOSE: Major depression is associated with high levels of absence and reduced productivity. Therefore the costs to society are high. The aim of this study was to evaluate the cost-utility of collaborative care for major depressive disorder (MDD) compared to care as usual in an occupational healthcare setting. A societal perspective was taken. METHODS: In this randomised controlled trial, 126 sick-listed workers with MDD were included (65 collaborative care, 61 care as usual). Baseline measurements and follow up measures (3, 6, 9 and 12 months) were assessed by questionnaire. We applied the Trimbos/iMTA questionnaire for costs associated with psychiatric illness, the SF-HQL and the EQ-5D respectively measuring the health care utilization, production losses and general health related quality of life. RESULTS: The average annual healthcare costs in the collaborative care group were €3,874 (95 % CI €2,778-€ 5,718) compared to €4,583 (95 % CI €3,108-€6,794) in the care as usual group. The average quality of life years (QALY's) gained were lower in the collaborative care group, 0.05 QALY. The majority of the ICERS (69 %) indicate that collaborative care is less costly but also less effective than care as usual. Including the productivity costs did not change this result. CONCLUSIONS: The cost-utility analysis showed that collaborative care generated reduced costs and a reduction in effects compared to care as usual and was therefore not a cost-effective intervention.
Authors: Christina M van der Feltz-Cornelis; Rob Hoedeman; Fransina J de Jong; Jolanda Ac Meeuwissen; Hanneke W Drewes; Niels C van der Laan; Herman J Adèr Journal: Neuropsychiatr Dis Treat Date: 2010-09-07 Impact factor: 2.570
Authors: Moniek C Vlasveld; Christina M van der Feltz-Cornelis; Herman J Adèr; Johannes R Anema; Rob Hoedeman; Willem van Mechelen; Aartjan T F Beekman Journal: Occup Environ Med Date: 2012-10-30 Impact factor: 4.402
Authors: David A Adler; Thomas J McLaughlin; William H Rogers; Hong Chang; Leueen Lapitsky; Debra Lerner Journal: Am J Psychiatry Date: 2006-09 Impact factor: 18.112
Authors: S E Lagerveld; U Bültmann; R L Franche; F J H van Dijk; M C Vlasveld; C M van der Feltz-Cornelis; D J Bruinvels; J J J M Huijs; R W B Blonk; J J L van der Klink; K Nieuwenhuijsen Journal: J Occup Rehabil Date: 2010-09
Authors: Myrthe van Vilsteren; Sandra H van Oostrom; Henrica C W de Vet; Renée-Louise Franche; Cécile R L Boot; Johannes R Anema Journal: Cochrane Database Syst Rev Date: 2015-10-05
Authors: Thomas Grochtdreis; Christian Brettschneider; Annemarie Wegener; Birgit Watzke; Steffi Riedel-Heller; Martin Härter; Hans-Helmut König Journal: PLoS One Date: 2015-05-19 Impact factor: 3.240
Authors: Iman Elfeddali; Christina M van der Feltz-Cornelis; Jim van Os; Susanne Knappe; Eduard Vieta; Hans-Ulrich Wittchen; Carla Obradors-Tarragó; Josep Maria Haro Journal: Int J Environ Res Public Health Date: 2014-10-21 Impact factor: 3.390
Authors: Eric W de Heer; Jack Dekker; Aartjan T F Beekman; Harm W J van Marwijk; Tjalling J Holwerda; Pierre M Bet; Joost Roth; Lotte Timmerman; Christina M van der Feltz-Cornelis Journal: Front Psychiatry Date: 2018-04-05 Impact factor: 4.157
Authors: K L Cullen; E Irvin; A Collie; F Clay; U Gensby; P A Jennings; S Hogg-Johnson; V Kristman; M Laberge; D McKenzie; S Newnam; A Palagyi; R Ruseckaite; D M Sheppard; S Shourie; I Steenstra; D Van Eerd; B C Amick Journal: J Occup Rehabil Date: 2018-03
Authors: Elisabeth Björk Brämberg; Kristina Holmgren; Ute Bültmann; Hanna Gyllensten; Jan Hagberg; Lars Sandman; Gunnar Bergström Journal: BMC Public Health Date: 2018-07-18 Impact factor: 3.295
Authors: Christine Preiser; Eva Rothermund; Andrea Wittich; Harald Gündel; Monika A Rieger Journal: Int Arch Occup Environ Health Date: 2015-11-12 Impact factor: 3.015
Authors: Maartje Goorden; Christina M van der Feltz-Cornelis; Kirsten M van Steenbergen-Weijenburg; Eva K Horn; Aartjan Tf Beekman; Leona Hakkaart-van Roijen Journal: Neuropsychiatr Dis Treat Date: 2017-07-18 Impact factor: 2.570
Authors: Iben Axén; Elisabeth Björk Brämberg; Marjan Vaez; Andreas Lundin; Gunnar Bergström Journal: Int Arch Occup Environ Health Date: 2020-04-03 Impact factor: 3.015